Welcome to my Neuroendocrine Cancer terms and definitions list providing a source of meanings for acronyms and medical terms, all sourced from top cancer/Neuroendocrine Cancer sites. This version is a simple combination of an intelligent search (e.g. type first character to filter etc) plus a simple long list of all the terms in my repository. But each has a link which will direct you to the definition of the term plus where applicable, links to any of my articles where I have tagged this term (therefore providing added context). Please note I’m constantly working on the repository to clean up all definitions, adding and removing links where necessary, and ensuring all definitions are linked to at least one article. Where a definition is not yet linked to an article, the definition will still be listed, and you will see a message saying “nothing found” and offering you a search of my entire website. The large long list below entitled “Full list of terms” is the 0 to 9 and A to Z list of terms in my database. If you’re happy just scrolling down the list of terms it will work for you. The number in brackets after a term is the number of posts linked to that term. Each term is linked to the definition at the top and then below, links to the posts where the definition is further defined with some context. Press the back button on your browser anytime to return to the database. A very basic search facility is currently there entitled “Tags” – it is sitting just above the Full list of terms. You will see a drop down if you click in the search bar but if you do not select a tag this way and simply type in the first letter/number of the term, it filters the list down so you can find something quicker. I hope to build an easier search bar in due course – but see the next paragraph. I generated this version to help certain iPhone users who have issues reading my posts. But please note there is another version of this database built in my fuill website page builder. You can read this version with a fully clickable 0-9 and A-Z box to reduce the full list available. Plus it has a language translator. Click here. Thanks for supporting this repository which started as a 2020 “lock-down” project. I’m always looking for volunteers to help me proof check the content and make suggestions for changes including inclusions. Let me know if you can help (message me on my Facebook pages but I will shortly produce a form to send messages to me direct from this post, hoping to incorporate it soon). Ronny
Full list of terms (click on the term to see the meaning and any associated posts)
- 111In-DTPA-D-Phe1 (2)
- 123I-Metaiodobenzylguanidine (mIBG) (2)
- 131I-Metaiodobenzylguanidine (mIBG) (3)
- 177Lu OPS 201 (1)
- 177Lu-DOTA-EB-TATE (1)
- 177Lu-DOTA-LM3 (1)
- 177Lu-Edotreotide (Solucin®) (5)
- 177Lu-PSMA-R2 (1)
- 18F-FDG (5)
- 18F-FDG PET/CT (3)
- 18F-FDOPA (2)
- 212Pb (2)
- 212Pb-AR-RMX (3)
- 225Ac (2)
- 24-hour urinary catacholamines and metanephrines (2)
- 5-Fluorouracil (5-FU) (3)
- 5-HIAA (15)
- 5-HT (5)
- 5-HT3 (1)
- 5-HT3-RA (1)
- 5-HTP (2)
- 5-Hydrotryptophan (5-HTP) (5)
- 5-Hydroxyindoleacetic Acid (5-HIAA) (2)
- 5-Hydroxytryptamine (5-HT) (3)
- 64Cu-DOTATATE (6)
- 64Cu-SARTATE (1)
- 67Cu-SARTATE (1)
- 68Ga edotreotide (TOCscan®) (1)
- 68Ga-PSMA-R2 (1)
- 75Se-homocholic acid taurine (75SeHCAT) (1)
- Ablation (6)
- Ac-225 (2)
- Achlorhydria (1)
- Acid reflux (3)
- Acromegaly (3)
- ACTHoma (1)
- Actin (1)
- Addison's disease (1)
- Adenocarcinoma (2)
- Adenoma (1)
- Adhesions (2)
- Adjuvant surgery (1)
- Adrenal glands (2)
- Adrenal insufficiency (1)
- Adrenal medulla (2)
- Adrenaline (4)
- Adrenocortical Carcinoma (ACC) (2)
- Adrenocorticotropic Hormone (ACTH) (6)
- Advanced neuroendocrine cancer (244)
- AdVince (1)
- Afinitor (21)
- Albumin (1)
- Alcohol (3)
- Alcohol flushing reaction (2)
- ALDH2 (1)
- Aldosterone (1)
- Allergies (2)
- Alopecia (1)
- Alternative medicine (7)
- Alternative therapies (6)
- American Society of Clinical Oncology (ASCO) (1)
- Amines (3)
- Amino acids (1)
- Ampulla (1)
- Ampulla of Vater (1)
- Amylase (1)
- Anaphylactic shock (1)
- Anaplastic (1)
- Androgrens (1)
- Anesthesia (1)
- Angioedema (1)
- Angioma (1)
- Anorexia (1)
- Antagonist (1)
- Anti-angiogenic therapy (1)
- Antiacids (2)
- Antibiotics (1)
- Antibody drug conjugate (2)
- Anticoagulant (1)
- Antidepressant (3)
- Antihistamines (2)
- Antineoplastic therapy (1)
- Anxiety (23)
- AOH1966 (1)
- Appendectomy (2)
- Appendiceal NET (7)
- Appendix (2)
- Aretha Franklin (4)
- Arterial embolization (1)
- Ascending colon (1)
- Asthma (2)
- ASTX727 (1)
- Atezolizumab (Tecentriq) (3)
- Atopic dermatitis (1)
- Atrophic gastritis (3)
- ATRX (1)
- Atypical carcinoid tumour (2)
- Atypical Lung NET (3)
- Autosomal dominant (1)
- Avelumab (Bavencio) (2)
- Avistan (2)
- Axid (Nizatidine) (1)
- Axillary nodes (5)
- AZEDRA (1)
- B12 (2)
- B3 (1)
- BAM (2)
- Barrett's Esophagus (2)
- Bavencio (1)
- Benign (4)
- Benign NET (2)
- Benign tumour (5)
- Bevacizumab (2)
- Biased agonist (1)
- Bile (1)
- Bile acid diarrhea (3)
- Bile acid malabsorption (7)
- Bile acid sequestrant (4)
- Bile acids (1)
- Bile duct (1)
- Bile salt (4)
- Biliary tract cancer (1)
- Biogenic amines (1)
- Biological therapy (1)
- Biomarker (2)
- Biopsy (17)
- Bland liver embolization (1)
- Blood brain barrier (BBB) (1)
- Blood clot (2)
- Blood glucose (3)
- Blood test (1)
- Blue Book (3)
- Bone marrow biopsy and aspiration (1)
- Bone metastases (4)
- Bowel cancer (8)
- Bowel obstruction (4)
- Bowel surgery (8)
- Bradykinin (4)
- Brain serotonin (3)
- Brain tumour (2)
- Breast cancer (6)
- Breast NEN (1)
- Broken capillaries (1)
- Bronchial NET (1)
- Bronchopulmonary Neuroendocrine Neoplasms (BP NEN) (4)
- Bronchoscopy (2)
- Butt dart (2)
- Bynfezia Pen (2)
- C-peptide (1)
- CA4P (1)
- Cabometyx (1)
- Cabozantinib (4)
- Calcitonin (3)
- Calcitonin gene-related peptide (CGRP) (2)
- Calcitoninoma (1)
- Calcium (1)
- Camera pill (1)
- Cancer (10)
- Cancer anger (1)
- Cancer causes (5)
- Cancer grading (6)
- Cancer of unknown primary (CUP) (5)
- Cancer registries (1)
- Cancer related fatigue (5)
- Cancer research (3)
- Cancer staging (5)
- Cancer surveillance (14)
- Cancer survivor (22)
- Cancer vaccine (2)
- Cancerous tumour (1)
- Cancerversary (4)
- Capecitabine (Xeloda) (4)
- CAPecitabine TEMozolomide (CAPTEM). (7)
- Capsule endoscopy (1)
- CAPTEM (5)
- CAR-T (1)
- Carbocaine (1)
- Carboplatin (3)
- Carcinoid (8)
- Carcinoid crisis (30)
- Carcinoid heart disease (18)
- Carcinoid rage (2)
- Carcinoid syndrome (131)
- Carcinoid tumour (87)
- Carcinoma (2)
- Cardiopulmonary hemodynamic instability (2)
- Carney-Stratakis syndrome (CSS) (3)
- Catecholamines (5)
- C‑Reactive Protein (CRP) (1)
- CB-839 (1)
- CDKN1B (1)
- Cerebellum (1)
- Chemo bath (1)
- Chemotherapy (30)
- Chinese dumplings (1)
- Cholecalciferol (1)
- Cholecystectomy (1)
- Cholestyramine (1)
- Chromaffin cells (3)
- Chromogranin (2)
- Chromogranin A (CgA) (7)
- Chromogranin B (CgB) (2)
- Chromogranin C (CgC) (2)
- Chronic condition (3)
- Cimetidine (1)
- Cisplatin (4)
- Cisplatin/Etoposide (2)
- CLARINET (3)
- Clexane (2)
- Clinical trial (39)
- CLO test (1)
- Coeliac disease (1)
- Cognitive behavioural therapies (CBT) (1)
- Colon cancer (4)
- Colon NET (1)
- Colonoscopy (3)
- Colony stimulating factor-1 receptor (CSF-1R) (1)
- Colorectal cancer (6)
- Combined Neuroendocrine Carcinoma (1)
- Combretastatin A-4 phosphate (CA4P) (1)
- Cometriq (1)
- Comorbidity (1)
- COMPETE trial (2)
- Complete blood count (CBC) (1)
- Complex regional pain syndrome (CRPS) (1)
- Constipation (5)
- CONTROLNETS (1)
- COR-003 (1)
- COR-005 (1)
- Core Biopsy (3)
- Coronavirus (3)
- Corticotrophin releasing hormone (CRH) (1)
- Cortisol (4)
- COVID-19 (29)
- Creon (2)
- CRN00808 (1)
- CRN01941 (1)
- Crohn's Disease (2)
- Cryoablation (2)
- CT enterography (1)
- CT guided aspiration (1)
- CT scan (15)
- Cu-61 (1)
- Curative surgery (2)
- Cure (3)
- Cushing's disease (6)
- Cushing's syndrome (10)
- Cyberchondria (1)
- Cyberknife (1)
- Cytoreductive (2)
- Cytotoxic (1)
- DAXX (1)
- Debulking surgery (15)
- Degenerative bone disease (2)
- Depression (6)
- Dermal fibrosis (1)
- Dermatitis (1)
- Desmoplasia (10)
- Detectnet (1)
- DEXA scan (1)
- Dexilent (1)
- Dexlansoprazole (1)
- Diabetes (10)
- Diagnosis (34)
- Diarrhea (29)
- Diet (28)
- Differential diagnosis (5)
- Differentiation (5)
- Diffuse hepatic steatosis (1)
- Digestive enzymes (3)
- DIPNECH (1)
- Distal pancreatectomy (2)
- Distant metastatis (5)
- Distributive shock (1)
- Diverticulitis (1)
- DLL3 (4)
- DNA (2)
- DNA methylation-based profiling (2)
- Do no harm (1)
- Doctor Google (Dr. Google) (2)
- Dopamine (3)
- Dopamine receptors (1)
- Dostarlimab (1)
- DOTA-NOC (1)
- DOTA-TATE (2)
- DOTA-TOC (2)
- DP1038 (1)
- Drug-Eluting Beads DEB-TACE (1)
- Dry skin (2)
- DUNE trial (1)
- Duodenal NET (dNET) (4)
- Duodenum (2)
- Durvalumab (1)
- Dysbiosis (1)
- Early Diagnosis (3)
- ECG (1)
- Echocardiogram (2)
- Ectopic Cushing’s syndrome (ECS) (4)
- Eczema (1)
- Edotreotide (2)
- EGFR (1)
- ELECT study (2)
- Electrolytes (1)
- Eliquis (apixaban) (1)
- Endocrine (8)
- Endocrine function (pancreas) (1)
- EndolucinBeta (2)
- Endoscopic retrograde cholangiopancreatography (ERCP) (1)
- Endoscopic ultrasound (EUS) (6)
- Endoscopy (4)
- ENETS (9)
- Enterade® advanced oncology formula (1)
- Enterochromaffin cells (1)
- Enucleation (1)
- EPAS1 (1)
- Epi pens (1)
- Epidemiology (10)
- Epidermal growth factor receptor (EGFR) (1)
- Epinephrine (5)
- Erythrocyte sedimentation rate (ESR) (1)
- Esomeprazole magnesium (1)
- Essiac therapy (Essiac tea) (1)
- Estrogen (2)
- Ethanol (2)
- Etoposide (3)
- EUS (1)
- Everolimus (23)
- Exocrine cells (1)
- Exocrine function (pancreas) (2)
- Exocrine pancreatic insufficiency (2)
- Explorer PET scan (1)
- External beam radiotherapy (1)
- extra (1)
- False negative (1)
- False positive (1)
- Familial medullary thyroid cancer (FMTC) (6)
- Familial NET (2)
- Famotidine (1)
- Fasting Gut Endocrine Profile (1)
- Fat malabsorption (3)
- Fat soluble vitamins (4)
- Fatigue (5)
- Fatty liver (1)
- FCarboSt (1)
- Fecal bile acid test (1)
- Fecal elastase test (1)
- Fecal fat (1)
- FH (1)
- Fibre (1)
- Fibroblast growth factor receptor (FGFR) (2)
- Fibrosis (1)
- Fight or flight (1)
- Fine needle aspiration (FNA) (3)
- Flu (1)
- Fluorine-18 (1)
- Fluoro-18-L-Dihydroxyphenylalanine (1)
- Fluoropyrimidine (1)
- Fluorouracil (5-FU) (1)
- Flushing (32)
- Focal fatty sparing (1)
- FODMAP (2)
- FOLFIRI (2)
- FOLFOX (2)
- Follicular cell (1)
- Food allergy (2)
- Food and Drug Administration (1)
- Foregut (3)
- Fosbretabulin tromethamine (1)
- Fructose intolerance (3)
- Full blood count (FBC) (1)
- Full remission (2)
- Functional tumour (6)
- G protein-coupled receptors (GPCR) (1)
- Ga68 PET/CT (33)
- Ga68-DOTA-JR11 (1)
- Ga68-DOTANOC (1)
- Ga68-DOTATATE (3)
- Ga68-DOTATOC (2)
- Ga68-FAPI PET/CT (1)
- Ga68-OPS202 (1)
- Gallbladder (3)
- Gallium 68 (Ga68) (2)
- Gamma camera (1)
- Gamma knife (1)
- Gastric NET (10)
- Gastrin (7)
- Gastrin pH (2)
- Gastrinoma (17)
- Gastro-entero-pancreatic neuroendocrine tumour (GEP-NET) (23)
- Gastroenterologist (2)
- Gastroesophageal reflux disease (GERD) (2)
- Gastrointestinal NET (GI-NET) (4)
- Gastroscopy (1)
- Generator (radionuclide) (1)
- Generic drugs (3)
- Genetic testing (4)
- Genetics (4)
- Genito-urinary NET (1)
- Germline genetic mutations (1)
- Gerson therapy (1)
- GHRHoma (1)
- Glioma (1)
- Gliomablastoma (1)
- GLP-1 (1)
- Glucagon (6)
- Glucagonoma (13)
- Glucose (cancer sugar myth) (1)
- Glycated Hemoglobin (A1C) (1)
- Goitre (1)
- Gonadotropin-releasing hormone (GnRH) (1)
- Grade (5)
- Grading (3)
- Granulinoma (1)
- Graves’ disease (2)
- Green tea (1)
- Ground glass opacities (2)
- Growth hormone (GH) (1)
- Gut (1)
- Gut Flora (3)
- H2 blockers (1)
- H2 receptor antagonist (H2RA) (2)
- Haemangioblastoma (1)
- Haemoglobin (hemoglobin) (1)
- Hashimoto's disease (2)
- HbA1c (2)
- Head and Neck Cancer (2)
- Heart disease (1)
- Heat intolerance (1)
- Hedinger syndrome (10)
- Helicobacter pylori (1)
- Hemangioma (1)
- Hemoglobin (1)
- Hereditary cancer syndrome (4)
- Hereditary pheochromocytoma/paraganglioma syndromes (6)
- Heterogeneity (3)
- Heterogeneous (4)
- High Grade NEC (3)
- High grade neuroendocrine neoplasm (NEN) (7)
- High grade neuroendocrine tumour (NET) (6)
- High Residue Diet (2)
- High-intensity focused ultrasound (HIFU) (3)
- Hindgut (2)
- Histamine (9)
- Histotripsy (4)
- Hives (2)
- Hodgkin lymphoma (4)
- Hormonal crisis (3)
- Hormone therapy (1)
- Hormones (65)
- Hospice care (1)
- Hotspot (1)
- HPA axis (1)
- Hurthle cell neoplasm (1)
- Hydrocele (3)
- Hydrocelectomy (1)
- Hydrogen breath test (1)
- Hydronephrosis (1)
- Hyperadrenergic (1)
- Hypercalcemia (1)
- Hypercortisolism (3)
- Hypergastrinemia (3)
- Hyperglycemia (1)
- Hyperhidrosis (1)
- Hyperinsulinism (1)
- Hyperparathyroidism (1)
- Hypertension (6)
- Hyperthermic intraperitoneal chemotherapy (HIPEC) (2)
- Hyperthryroidism (4)
- Hypervascularity (1)
- Hypocortisolism (1)
- Hypoglycemia (3)
- Hypokalemia (2)
- Hypotension (2)
- Hypothalamus (1)
- Hypothyroidism (8)
- IBS (4)
- IBS-C (1)
- IBS-D (1)
- IBS-M (1)
- Ileum (1)
- Immunotherapy (17)
- Imodium (1)
- Incidence (5)
- Incidental diagnosis (3)
- Incidentaloma (1)
- Incomplete emptying (1)
- Incurable cancer (76)
- Indium 111-pentetreotide (3)
- Inflammatory bowel disease (IBD) (3)
- Insulin (4)
- Insulin-like growth factor 1 (IGF-1) (1)
- Insulinoma (13)
- Interferon alpha (IFNα) (1)
- Intermediate grade NET (3)
- International Classification of Diseases (ICD) (1)
- International Classification of Diseases for Oncology (ICD-O) (1)
- Intestinal ischaemia (1)
- Intraoperative chemotherapy (1)
- Intraoperative hypertensive crisis (4)
- Intraoperative radiotherapy (IORT) (2)
- Invisible illness (15)
- Iobenguane I 131 (1)
- Ipilimumab (Yervoy) (2)
- Irinotecan (Campto) (2)
- Iron Deficiency Anaemia (4)
- Irreversible electroporation (IRE) (1)
- Irritable bowel syndrome (IBS) (6)
- Islet cell (1)
- Islet of Langerhams (1)
- JR11 (2)
- Kallikrein (1)
- Karzinoide (1)
- Ketogenic diet (2)
- Keytruda (3)
- Ki-67 (5)
- Kidney (1)
- Lactose intolerance (4)
- Lactulose (2)
- Laetrile (amygdalin or vitamin B17) (1)
- Lanreotide (67)
- Lansoprazole (1)
- Laparoscopic surgery (4)
- Large cell neuroendocrine carcinoma (LCNEC) (7)
- Late Diagnosis (2)
- Lenvatinib (Lenvima) (1)
- Lenvima (1)
- Leukaemia (US Leukemia) (1)
- Levoketoconazole (Recorlev) (1)
- Levothyroxine (5)
- Lipase (1)
- Liquid biopsy (2)
- Liver (1)
- Liver cyst (2)
- Liver directed therapy (7)
- Liver embolization (6)
- Liver lesion (2)
- Liver metastases (18)
- Loperamide hydrochloride (2)
- Low Grade NETs (6)
- Low residue diet (1)
- Lu 177 dotatate (2)
- Lu-177 (7)
- lung (1)
- Lung Cancer (12)
- Lung NETs (32)
- Lung nodule (5)
- Lutathera (26)
- Luteinizing hormone (LH) (1)
- Lutetium 177 (1)
- LUTIA clinical trial (1)
- Lymph nodes (2)
- Lymphadenectomy (5)
- Lymphatic system (3)
- Lymphedema (1)
- Lymphoma (2)
- Lynch syndrome (1)
- Magnetic resonance imaging (MRI) scan (4)
- Malabsorption (32)
- Malignant (5)
- Malvern Hills (1)
- Mammalian target of rapamycin (mTOR) inhibitor (3)
- Mammogram (1)
- MANEC (1)
- Marcaine (1)
- Mast cell (1)
- Mastocytosis (2)
- MDH2 (1)
- Medical food (1)
- Medicines and Healthcare Products Regulatory Agency (1)
- Medullary thyroid cancer (MTC) (7)
- Melanoma (3)
- Melatonin (1)
- MEN1 syndrome (12)
- MEN2 syndrome (6)
- MEN2A syndrome (5)
- MEN2B syndrome (5)
- MEN4 syndrome (2)
- MEN5 syndrome (1)
- Meningioma (1)
- Menopause (1)
- MENX (1)
- Merkel cell carcinoma (6)
- Mesenteric Fibrosis (1)
- Mesenteric root (2)
- Mesentery (4)
- Metanephrines (2)
- Metastatic Neuroendocrine Cancer (152)
- MIBG scan (1)
- Microsatellite instability-high (MSI-H) (1)
- Midgut (4)
- Mineral (1)
- Misdiagnosis (6)
- Mitotic count (1)
- Mitotic rate (1)
- Mixed Neuroendocrine Non-Neuroendocrine Neoplasms (MiNEN) (3)
- mNRA (1)
- Molecular markers (6)
- Monoamine oxidase inhibitors (MAOIs) (1)
- Monoclonal antibodies (3)
- MTD201 (2)
- mTOR inhibitor (4)
- Multi tyrosine kinase inhibitors (TKIs) (2)
- Multidisciplinary team (MDT) (6)
- Multikinase inhibitor (1)
- Multimodal treatment (1)
- Multiple Endocrine Neoplasia (MEN) (10)
- Multiple myeloma (2)
- Mushrooms (1)
- MYCAPSSA (2)
- Myeloma (1)
- NanoKnife® (1)
- National Cancer Institute (1)
- National Institute for Health and Care Excellence (NICE) (1)
- National Institutes of Health (1)
- Nausea (1)
- Neoplasm (1)
- NET Cancer Day (4)
- NET Centre of Excellence (4)
- NET syndromes (49)
- Netazepide (1)
- NETDetect (1)
- NETest (5)
- NETSPOT (8)
- NETTER-1 (4)
- NETTER-2 (2)
- NETTER-3 (1)
- Neuroblastoma (3)
- Neuroendocrine (102)
- Neuroendocrine cancer (313)
- Neuroendocrine carcinoma (NEC) (133)
- Neuroendocrine neoplasm (NEN) (47)
- Neuroendocrine tumour (NET) (223)
- Neurofibromatosis type 1 (NF1) (3)
- Neurokinin A (NKA) (2)
- Neurologic paraneoplastic syndromes (1)
- Neuropeptide K (1)
- Neurotensin (1)
- Neurotransmitter (2)
- Nexium (1)
- NF1 (1)
- NHS (2)
- Niacin (1)
- Night sweat (1)
- Nivolumab (Opdivo) (5)
- Nizatidine (1)
- NKA (1)
- No evidence of disease (NED) (3)
- No-Carrier-Added Lutetium-177 (n.c.a. Lu177) (1)
- Nodule (3)
- Noid (1)
- Non-functional tumour (6)
- Non-Peptide drug conjugate (1)
- Non-small cell lung cancer (NSCLC) (1)
- Noradrenaline (1)
- Norepinephrine (3)
- North American Neuroendocrine Tumor Society (NANETS) (1)
- Novocaine (1)
- NT-proBNP (2)
- Nuclear medicine (4)
- Nutrition (42)
- Nutrizym (1)
- Octreo-ratiopharm® (1)
- Octreoscan (Octreotide scan) (5)
- Octreotide (49)
- Octreotide (Octreotide acetate) (1)
- Octreotide scan (18)
- Octreotide soak (2)
- Octreotide-RP (2)
- Olaparib (1)
- Olatuton® (1)
- Omega 3 (1)
- Omeprazole (1)
- Omeprazole and sodium bicarbonate (1)
- ONC201 (1)
- Oncologist (1)
- Oncolytic virus (4)
- Ondansetron (Zofron) (1)
- Opdivo (Nivolumab) (2)
- Osteoblastic activity (1)
- Ovarian cancer (1)
- Ovarian NEN (1)
- Overactive thyroid (1)
- Overdiagnosis (2)
- Oxaliplatin (Eloxatin) (1)
- Oxitriptan (1)
- Oxytocin (1)
- Paclitaxel (Taxol) (2)
- Palliative care (4)
- Palliative treatment (4)
- Palpitation (2)
- Pancreas (1)
- Pancrease (1)
- Pancreastatin (3)
- Pancreatic adenocarcinoma (3)
- Pancreatic cancer (29)
- Pancreatic cyst (2)
- Pancreatic enzyme replacement therapy (PERT) (5)
- Pancreatic insufficiency (2)
- Pancreatic NET (PanNET) (43)
- Pancreatic polypeptide (PP) (3)
- Pancreatic pseudocyst (3)
- Pancreatic uncinate process (1)
- Pancreatin (1)
- Pancreatogenic diabetes (1)
- Pancreoprivic diabetes (1)
- Pancrex (1)
- Pantoloc control (1)
- Pantoprazole (1)
- Papillary thyroid cancer (1)
- Paraganglia (1)
- Paraganglioma (30)
- Paraneoplastic syndromes (2)
- Parathyroid gland (3)
- Parathyroid NET (1)
- Parotid gland NET (1)
- PARP Inhibitor (1)
- Partial remission (2)
- Pasireotide (2)
- Patent foramen ovale (PFO) (1)
- Pathology (4)
- PD-1/PD-L1 Inhibitors (3)
- PDR001 (2)
- Pellagra (1)
- Pembrolizumab (Keytruda) (5)
- Pemetrexed disodium (1)
- PEN-221 (1)
- Pentetreotide (2)
- Pepcid (Famotidine) (2)
- Peptide (2)
- Peptide receptor radionuclide therapy (PRRT) (43)
- Peripheral Serotonin (2)
- Peritoneal carcinomatosis (2)
- Pernicious anaemia (3)
- PET Scan (5)
- Pheochromocytoma (44)
- Physician (1)
- Physiological uptake (4)
- PI3K inhibitor (1)
- Pituitary gland (3)
- Pituitary NET (PitNET) (1)
- Plasma 5HIAA (2)
- Platelet-derived growth factor receptor (PDGFR) (1)
- Pleural Fibrosis (1)
- pNET (6)
- Poorly differentiated (13)
- Post operative seroma (1)
- PPoma (8)
- PRCRT (3)
- Pre-existing condition (1)
- Prediabetes (1)
- Pressor amines (2)
- Prevacid (Lansoprazole) (1)
- Prevalence (3)
- Prilosec (Omeprazole) (1)
- Probiotic (7)
- Procaspase-activating compound-1 (PAC-1) (1)
- Prognosis (12)
- Progressive cancer (1)
- Proinsulin (1)
- Proliferative rate (1)
- Prostaglandin (3)
- Prostate Cancer (4)
- Protease (1)
- Proteasome inhibitors (1)
- Protein kinase inhibitor (1)
- Proton beam therapy (1)
- Proton pump inhibitors (PPI) (5)
- Protonix (Pantoprazole) (1)
- PRRT (47)
- Pruritus (1)
- Pseudomyxoma peritonei (PMP) (3)
- PTHrPoma (1)
- Pulmonary embolism (4)
- Pulmonary fibrosis (1)
- PV-10 (1)
- Q-Octreotide (2)
- Q-Sphera (1)
- Quality of LIfe (QoL) (96)
- Rabeprazole (Aciphex) (1)
- RADIANT (2)
- Radiation therapy (1)
- Radio Frequency Ablation (RFA) (2)
- Radioactive iodine (1)
- Radioembolization (1)
- Radioimmunotherapy (1)
- Radiolabelled somatostatin analogue (5)
- Radioligand (2)
- Radioligand therapy (3)
- Radionuclide (6)
- Radiopeptide (1)
- Radiotherapy (3)
- Ranitidine (Zantac) (1)
- Rash (1)
- RECORLEV (levoketoconazole) (1)
- Rectal cancer (2)
- Rectal NET (4)
- Red blood count (RBC) (1)
- Remission (1)
- Renal cell carcinoma (RCC) (1)
- Renal cyst (2)
- Renal insufficiency (1)
- Residue (food) (1)
- RET (1)
- Retroperitoneal Fibrosis (13)
- Retroperitoneum (1)
- Right hemicolectomy (6)
- Rosacea (3)
- Rose Bengal (1)
- Sandostatin (6)
- Sapanisertib (1)
- SARTATE™ (1)
- Satoreotide (Lutetium-177) (2)
- SB NET (1)
- Scan (4)
- Scanxiety (9)
- SCF node (1)
- Scleroderma (1)
- SDHA (2)
- SDHAF2 (1)
- SDHAF2(SDH5) (1)
- SDHB (2)
- SDHC (2)
- SDHD (1)
- SEER (5)
- Selective Internal Radiotherapy (SIRT) (1)
- Selective Serotonin Reuptake Inhibitor (SSRI) (2)
- Semaglutide (1)
- Serotonin (31)
- Serotonin and norepinephrine reuptake inhibitor (SNRI) (1)
- Serotonin syndrome (2)
- Serum 7αC4 test (1)
- Serum serotonin (2)
- Setrons (1)
- SI NET (8)
- Side effect (4)
- Siegfried Oberndorfer (1)
- Sigmoidoscopy (1)
- SIGNIFOR® (Pasireotide) (2)
- Skin NET (1)
- Sleep hyperhidrosis (1)
- Small cell lung cancer (SCLC) (15)
- Small cell neuroendocrine carcinoma (SCNEC) (4)
- Small intestine bacterial overgrowth (SIBO) (9)
- Small intestine NET (SI NET) (52)
- Solid tumour (4)
- Solucin ® (1)
- SOM230 (1)
- SomaKit TOC (4)
- Somatoprim (1)
- Somatostatin (3)
- Somatostatin analogues (74)
- Somatostatin receptor scintigraphy (SRS) (2)
- Somatostatin receptors (SSTR) (34)
- Somatostatinoma (12)
- Somatuline Autogel (US: depot) (14)
- Spartalizumab (1)
- special (1)
- SPECT (3)
- SPINET (2)
- Splenosis (1)
- Splenunculus (1)
- Squamous cell carcinoma (1)
- SSTR-PET (13)
- St. John's wort (1)
- Stable cancer (2)
- Stage (8)
- Standardised uptake value (SUV) (3)
- Steatorrhea (4)
- Stem Cell (1)
- Stereotactic body radiotherapy (SBRT) (4)
- Stereotactic radiosurgery (SRS) (2)
- Sternoclavicular joint (1)
- Stomach cancer (2)
- Stomach cramp (4)
- Stomach ulcer (1)
- Streptozotocin (Zanosar) (3)
- Stress (2)
- Subpectoral lymph node (1)
- Substance K (1)
- Substance P (4)
- Succinate Dehydrogenase Subunit Genes (SDHx) (1)
- Sulfatinib (1)
- Sunitinib (Sutent) (13)
- Superior mesenteric artery (1)
- Superior mesenteric vein (1)
- Supplements (4)
- Supraclavicularfossa (1)
- Supraclavicularfossa (SCF) lymph nodes (5)
- Surgeon (1)
- Surgery (96)
- Surufatinib (2)
- SurVaxM (2)
- Surveillance (6)
- Survivin (2)
- Survivor (4)
- Survivorship (21)
- Sweating (3)
- Sweet's syndrome (1)
- Symptom (2)
- Syndrome (4)
- Syndrome of inappropriate antidiuretic hormone secretion (SIADH) (2)
- Tachycardia (3)
- Tachykinin (4)
- Tagamet (1)
- Talazoparib (1)
- Targeted alpha-emitter therapy (TAT) (6)
- Targeted therapy (7)
- Tecentriq (Atezolizumab) (1)
- Technetium-99m (Tc-99m) (1)
- Telotristat ethyl (Xermelo) (10)
- Temozolomide (Temodal) (6)
- Teratoma (1)
- Terbium-161 (161Tb-DOTA-LM3) (1)
- Terminal cancer (3)
- Terminal ileum (2)
- Testicular cancer (2)
- Testosterone (1)
- The 5 E's (8)
- Theranostics (4)
- Thorson-Bioerck syndrome (8)
- Thymic NEN (2)
- Thyroid (5)
- Thyroid cancer (5)
- Thyroid NET (1)
- Thyroid nodule (2)
- Thyroid stimulating hormone (TSH) (2)
- Thyroiditis (1)
- Thyroxine (T4) (2)
- Tidutamab (1)
- TNM staging system (2)
- TOCscan® (1)
- Total gastrectomy (1)
- Total pancreatectomy (3)
- TPH1 (2)
- TPH2 (2)
- TraceNET (1)
- Trans arterial embolization (TAE) (1)
- Transarterial chemo embolization (TACE) (1)
- Transarterial embolizaton (TAE) (1)
- Transarterial radioembolization (TARE) (1)
- Travel with Ronny (2)
- Triapine (1)
- Tricyclic antidepressant (1)
- Triglycerides (1)
- Triiodothyronine (T3) (2)
- Tryptophan (4)
- Tryptophan hydroxylase (TPH) (3)
- Tuberous sclerosis (TSC) (2)
- Tumor board (4)
- Tumour marker (6)
- Tumour mutational burden (TMB) (2)
- Type 1 diabetes (1)
- Type 2 diabetes (3)
- Type 3c diabetes (2)
- Type 3c diabetes mellitus (T3cDM) (1)
- Typical lung NET (3)
- Tyramine (1)
- Tyrosine kinase inhibitor (TKI) (2)
- UKINETS (2)
- Ulcerative colitis (1)
- Ultrasound (2)
- Underactive thyroid (2)
- Ureter (1)
- Urticaria (1)
- Vaccine (3)
- Vanillylmandelic acid (VMA) (1)
- Vascular (2)
- Vascular disrupting agent (VDA) (1)
- Vascular endothelial growth factor (VEGF) (5)
- Vasoactive amines (2)
- Vasoactive intestinal peptide (VIP) (5)
- Vasoactive peptides (1)
- Vasodilation (1)
- Vasosuppressors (1)
- Vepesid) (2)
- Verner-Morrison syndrome (3)
- Vertebral haemangioma (1)
- Vimovo (1)
- VIPoma (14)
- Vitamin A (2)
- Vitamin ADEK (5)
- Vitamin B complex (1)
- Vitamin B1 (1)
- Vitamin B12 (6)
- Vitamin B2 (1)
- Vitamin B3 (1)
- Vitamin B5 (1)
- Vitamin B6 (1)
- Vitamin B7 (1)
- Vitamin B9 (1)
- Vitamin C (1)
- Vitamin D (6)
- Vitamin E (1)
- Vitamin K (1)
- VMT-𝛼-NET (1)
- Von Hippel-Lindau (VHL) Syndrome (6)
- Von Recklinghausen's disease (1)
- Watchful waiting (2)
- Water soluble vitamins (4)
- Watery diarrhea (1)
- Well differentiated (14)
- Wermer syndrome (1)
- Wheezing (1)
- Whipple procedure (4)
- Whipple's triad (3)
- White blood count (WBC) (1)
- World Health Organisation (WHO) (2)
- X-ray (1)
- XELOX. Oxaliplatin (Eloxatin) (1)
- Xermelo (Telotristat ethyl) (6)
- Yervoy (1)
- Yttrium 90 (Y90) (3)
- Zantac (2)
- Zebra (8)
- Zinc (1)
- Zofron (1)
- Zollinger-Ellison Syndrome (9)
